We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203

News   Jan 22, 2010

 
 4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203
 
 
Advertisement
 

RELATED ARTICLES

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Existing Drugs Could Stop SARS-CoV-2 From Hijacking Cells

News

A team has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The scientists have also identified seven existing drugs that could disrupt these mechanisms.

READ MORE

Making Moves With Cryo-EM

News

Researchers are solving long-standing mysteries about membrane protein structure using the power of cryo-EM.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE